One health care facilities player that insiders are loading up on here is Davita ( DVA), a provider of dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease. Insiders are buying this stock into some solid strength here, since shares are up over 35% so far in 2012. Davita has a market cap of $9.9 billion and an enterprise value of $14.09 billion. This stock trades at a reasonable valuation, with a trailing price-to-earnings of 19.22 and a forward price-to-earnings of 15.28. Its estimated growth rate for this year is 22.4%, and for next year it's pegged at 11.9%. This is not a cash-rich company, since the total cash position on its balance sheet is $282.07 million and its total debt is a whopping $4.52 billion. >>3 Health Care Stocks Under $10 Making Big Moves A beneficial owner just bought 282,403 shares, or about $28.81 million worth of stock, at $100.96 to $103.73 per share. From a technical perspective, DVA is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares soaring from a low of $77.81 to its recent high of $105.73 a share. During that uptrend, shares of DVA have been consistently making higher lows and higher highs, which is bullish technical price action. That move has how pushed DVA into range of triggering a near-term breakout trade. If you're bullish on DVA, then I would look for long-biased trades once it breaks out above some near-term overhead resistance at $105.73 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 698,102 shares. If that breakout triggers soon, then DVA will have a chance of trading up to $110 to $120 a share. Keep in mind that any move above $105.73 will push DVA into new 52-week-high territory, which is bullish technical price action. Davita was also featured in " 5 Stocks to Buy to Be Like Buffett."